COEGIN Share Price Performance
SEK 3.19
0.19 (6.33%)
Price SEK 3.19
Share Pricen/a
Analysis Article • Sep 17
Coegin Pharma AB Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
COEGIN Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
No trending discussion available.
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Coegin Pharma AB Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
- -0.69
- -169.81%
- -5,308.63%
- 0%
About COEGIN
- Founded
- 2005
- Employees
- 3
- CEO
- WebsiteView website
Coegin Pharma AB, a biotechnology company, develops and commercializes cosmetic technologies for hair and skin in Sweden. Its flagship product is Follicopeptide, a patented, clinically developed peptide technology targeting hair thinning; and NPP-4, a cosmetic peptide product designed to enhance skin tone without UV exposure or chemicals. The company also develops FOL026, a peptide drug candidate for the treatment of myocardial infarction; AVX420, a drug candidate for the treatment of leukemia; and AVX001, a drug candidate for the topical treatment of both actinic keratosis and basal cell carcinoma. Coegin Pharma AB was founded in 2005 and is headquartered in Lund, Sweden.
